Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
Screen a stock
TERMINAL
OP

OPKStockOPKO HEALTH, INC.

Nasdaq Global Select Market · Healthcare · US

$1.57 last close 2026-11-20
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment OPK's does — no target price to set, unlike a price alert.

Near limit Ratio screen, 4 of 4 decided standards passing. FTSE Shariah, MSCI Islamic, S&P Shariah, Usmani are within 3 points of their line. Even if they all crossed, the majority verdict would stay Not compliant. What would change it

Sharia status
NOT COMPLIANT
Per our in-house ratio engine · assessed 2026-08-28
Assessed 2026-08-28
4 of 4 pass our own screen — 3 of 7 could not be computed
Purification 100.00% *HTR non-permissible income 2.44%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 5 timeframes bullish · 69.6% aligned
VWAPPrice below VWAP ($1.63)
VolumeRelative volume 3.7× the 20-day average
Momentum10-day rate of change -7.2%

OPKO HEALTH, INC. (OPK) is currently considered not halal (non-compliant), per our in-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

434 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →

Market & analysts
Price target
$4.15
+164.3% · 5 analysts
Institutional own.
27.7%
of shares
Momentum (10d)
-7.2%
rate of change
SMC grade
F · 32
69.6% aligned
100.00% *
Purification ratio (secondary provider, uncertain)
2.44%
Non-permissible income — HTR, from filings (2025-12-31)
F · 32
SMC grade — 69.6% timeframe alignment
-7.2%
Rate of change (10d)
$4.15
Price target (+164.3%) · 5 analysts
27.7%
Institutional ownership

How the status reached this point

Non-compliant · status tracked since Nov 17, 2026

No change to OPK’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from the status this page publishes, last on Nov 21, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $1.2B as of 2026-11-18. At the 2026-11-20 close it is about $1.2B (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 3.1% (3.1% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 33.8% (33.5% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 2 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 3.11% 30.00% Pass(26.9pp buffer)
Interest-bearing investments 33.52% 30.00% Fail(3.5pp over)
Non-permissible income 2.44% 5.00% Pass(2.6pp buffer)
Usmani Pass 5 of 5 ratios pass
RatioValueThresholdResult
Interest-bearing debt 2.18% 33.00% Pass(30.8pp buffer)
Interest-bearing investments 21.44% 33.00% Pass(11.6pp buffer)
Non-liquid assets 74.29% at least 20.00% Pass(54.3pp above the floor)
Non-permissible income 2.44% 5.00% Pass(2.6pp buffer)
Net liquid assets per share $321.1M under mkt cap $1.2B Pass
MSCI Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 1.99% 33.33% Pass(31.3pp buffer)
Cash + interest-bearing securities 21.44% 33.33% Pass(11.9pp buffer)
Accounts receivable 25.71% 33.33% Pass(7.6pp buffer)
Non-permissible income 2.44% 5.00% Pass(2.6pp buffer)
FTSE Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.15% 33.33% Pass(33.2pp buffer)
Cash + interest-bearing securities 21.44% 33.33% Pass(11.9pp buffer)
Accounts receivable 25.71% 50.00% Pass(24.3pp buffer)
Non-permissible income 2.44% 5.00% Pass(2.6pp buffer)
Dow Jones Islamic Market Unverified⚠️ implied interest rate too low — debt may be double-counted 3 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 3.66% 33.00% Pass(29.3pp buffer)
Cash + interest-bearing securities 39.44% 33.00% Fail(6.4pp over)
Accounts receivable 7.85% 33.00% Pass(25.2pp buffer)
Non-permissible income 2.44% 5.00% Pass(2.6pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 3.67% 33.00% Pass(29.3pp buffer)
Cash + interest-bearing securities 39.62% 49.00% Pass(9.4pp buffer)
Accounts receivable 7.88% 49.00% Pass(41.1pp buffer)
Non-permissible income 2.44% 5.00% Pass(2.6pp buffer)
MSCI M-Series Unverified⚠️ implied interest rate too low — debt may be double-counted 3 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 3.67% 33.33% Pass(29.7pp buffer)
Cash + interest-bearing securities 39.62% 33.33% Fail(6.3pp over)
Accounts receivable 47.50% 49.00% Pass(1.5pp buffer)
Non-permissible income 2.44% 5.00% Pass(2.6pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

Usmani (% of total assets)non permissible income ratio 2.6pts
S&P Shariah Indices (% of 36-mo avg market cap)non permissible income ratio 2.6pts
MSCI Islamic Index (% of total assets)non permissible income ratio 2.6pts

The numbers the ratios are built from

Read from OPK's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $606.9M 2025-12-31 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $2.8M 2026-09-30 LongTermDebtNoncurrent, LongTermDebtCurrent
Cash and interest-bearing securitiesCash, equivalents and marketable securities $403.2M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $1.9B 2026-09-30 Assets
Market capDenominator for AAOIFI $1.2B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $1.0B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $1.1B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $14.8M 2025-12-31 InvestmentIncomeInterest

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-04, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-02-26, period ended 2025-12-31. Screened 2026-11-18.

  • Total assets$1.9B
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Interest-bearing debt$2.8M
    LongTermDebtNoncurrent $1.6M · period ended 2026-09-30 · 10-Q filed 2026-11-04
    LongTermDebtCurrent $1.2M · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Cash and interest-bearing securities$403.2M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Receivables$80.2M
    AccountsReceivableNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-11-04
  • Revenue$606.9M
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-02-26
  • Interest income (non-permissible)$14.8M
    InvestmentIncomeInterest · period ended 2025-12-31 · 10-K filed 2026-02-26
  • Market cap$1.2B
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

7 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for OPK. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for OPK has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 4 pass and 0 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.

Within 3 points of the line

FTSE Shariah, MSCI Islamic, S&P Shariah, Usmani are within 3 points of their line. Even if they all crossed, the majority verdict would stay Not compliant.

Shariah-compliant alternatives

Compliant companies in Diagnostics & Research listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
DHRDanaher Corp. $146.0B —
NTRANatera Inc $47.2B —
IDXXIdexx Laboratories, Inc. $44.1B —
AAgilent Technologies Inc. $43.3B —
WATWaters Corp. $37.3B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold OPK

3 of the 246 funds whose filed holdings we currently hold own OPK shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns OPK.

You may already own it

Widely held U.S. index funds. If you own one, you own OPK through it. None of them is a Shariah fund; the last column is our look-through of each.

FundOPK in fundFund compliant by weight
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00% 54%
SCHB Schwab U.S. Broad Market ETF 0.00% 53%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.00% 54%

Sorted by OPK’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names OPK once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding OPK
InvestorFirmPositionWeightAs of
Ken Griffin Citadel Advisors $5M 0.0% 2026-09-30
Peter Brown Renaissance Technologies $2M 0.0% 2026-09-30
Caxton Associates Caxton Associates LLP $0M 0.0% 2026-09-30
Paul Tudor Jones Tudor Investment Corp $0M 0.0% 2026-09-30
Steven Cohen Point72 Asset Management $0M 0.0% 2026-09-30
Mario Gabelli GAMCO Investors $0M 0.0% 2026-09-30
Israel Englander Millennium Management $0M 0.0% 2026-09-30
Joel Greenblatt Gotham Asset Management $0M 0.0% 2026-09-30
Jefferies Jefferies Financial Group $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

1.771.601.441.271.102025-11-242026-05-272026-11-20

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
1.44
S2
1.52
S1
1.56
PIVOT
1.64
R1
1.68
R2
1.76
R3
1.80

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
1.46 – 1.82
±10.72% from 1.64, made 2026-09-27 · resolves 2026-10-04
STRONG BUY
from 19 indicators
78.6% of our last 30385 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
4 buy · 0 neutral · 8 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)42.60NEUTRAL
Stochastic %K (14)6.45BUY
CCI (20)-144.24BUY
Williams %R (14)-93.55BUY
MACD (12,26,9)-0.02SELL
ROC (10)-9.25SELL
Momentum (10)-0.16SELL
EMA (10)1.64SELL
SMA (10)1.66SELL
EMA (20)1.65SELL
SMA (20)1.67SELL
EMA (30)1.63SELL
SMA (30)1.63SELL
EMA (50)1.60SELL
SMA (50)1.61SELL
EMA (100)1.53BUY
SMA (100)1.50BUY
EMA (200)1.42BUY
SMA (200)1.37BUY

About OPKO HEALTH, INC.

Healthcare · Diagnostics & Research

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system. This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency. The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test. OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.

opko.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

No real edge — avoid

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 64
⏰ 4H BEARISH 44
🕐 1H RANGING 98
⏱ 15-Min RANGING 130
⏲ 5-Min RANGING 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-7.2%
Rate of change (10d)
3.7×
Volume vs its 20-day average
0.01
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-17 · Asset managers net 895049 (-19081)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.